Skip to content

Thyroid-associated ophthalmopathy cohort study

Thyroid-associated ophthalmopathy cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019283
Enrollment
Unknown
Registered
2018-11-03
Start date
2018-11-05
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid-associated ophthalmopathy

Interventions

A:Glucocortieoid pulse therapy
B:Orbital radiotherapy
C:Follow-up observation

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients meeting the diagnostic criteria of Graves Orbitopathy according to the 2016 European Thyroid Association/European group

Exclusion criteria

Exclusion criteria: Without informed consent

Countries

China

Contacts

Public ContactXu Wenwei

Nanfang Hospital, Southern Medical University

xuww1988@126.com+86 13642685812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026